AstraZeneca
  • Bookmark This Page
  • Print This Page
  • Share with a Friend
Change Text Size
Change Text Size
Change Text Size
Change Text Size
Change Text Size

AstraZeneca has developed several programs especially for caregivers and kids dealing with asthma

About ASTHMAKIDCARE™

The ASTHMAKIDCARE program was created specifically for caregivers of children taking PULMICORT RESPULES and provides practical information and resources for managing their child’s asthma. Members receive seasonal newsletters and informational e-mails that provide useful information such as:

  • Tips on using PULMICORT RESPULES and nebulizers
  • Practical advice for managing their child’s asthma
  • Instructions for creating an Asthma Action Plan for home and school
  • Answers to the most frequently asked asthma questions
  • Referrals to other resources about asthma
  • Special offers on asthma care items

Your patients' caregivers can join the AsthmaKidCare program online at www.asthmakidcare.com

About the EVERYDAYKIDZ™ Program

Helping parents and caregivers manage their child’s asthma is very important, but it's not always easy. That's why AstraZeneca, a pioneer in pediatric respiratory research, developed EVERYDAYKIDZ—to help caregivers and their children with asthma connect by using educational tips and activities. It's specifically designed to help asthma treatment become part of the child's daily routine.

By joining Everydaykidz.com, your patients will be able to start enjoying our e-mail newsletters with tips and fun activities for families of children with asthma. They'll also have access to interactive tools such as videos, and fun craft projects parents can do with their child. And, they can also learn about screening events being held in their area.

Don’t let your patients miss Pulmi's Zone, where they can meet Pulmi, a 4-foot-tall, green thinga-ma-jiggie. Pulmi knows asthma inside and out. He also knows that asthma doesn't have to keep a kid from being, well, an everyday kid. Pulmi makes things easy to understand for moms, dads, and kids. And, he supports them all in having fun along the way.

“Next” Button
Learn about asthma screening tool

Indication and Important Safety Information

PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.

PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of acute bronchospasm.

Common adverse events reported in clinical trials, regardless of relationship to treatment, included respiratory infection, rhinitis, coughing, otitis media, viral infection, gastroenteritis, ear infection, oral thrush/candidiasis, and epistaxis.

Inhaled corticosteroids may cause a reduction in growth velocity. The long-term effect on final adult height is unknown.

PULMICORT RESPULES, like other inhaled corticosteroids, may impact the hypothalamic-pituitary-adrenal axis, especially in susceptible individuals, in young children, and in patients given high doses for prolonged periods.

Particular care is needed for patients who are transferred from systemically active corticosteroids to less systemically available corticosteroids, because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids (see WARNINGS in full Prescribing Information).

Patients taking immunosuppressant doses of corticosteroids should avoid exposure to infections such as chicken pox and measles.

[Please see accompanying full Prescribing Information (PDF).]